How to Track GLP-1 Progress Beyond the Scale
The scale can't tell fat loss from muscle loss on GLP-1 medications. Here's what to measure instead — body composition, waist, and metabolic markers.
Sidewalk Health
Table of contents
Share
You step on the scale, the number is down, and it feels like proof the medication is working. Then a week goes by and the number holds flat, or ticks up half a pound, and the doubt creeps in — is this still working? The problem isn't your progress. The problem is that a bathroom scale measures one thing (total mass) and says nothing about the two changes that actually matter on a GLP-1: how much fat you're losing, and how much muscle you're keeping. Two people can lose the identical fifteen pounds and be in completely different places physiologically. If the scale is your only instrument, you're flying with one gauge — and it's the wrong one.
This is a measurement problem, and measurement problems have measurement solutions. Here's what's worth tracking on a GLP-1, why each metric tells you something the scale can't, and how to build a simple baseline you can actually stick with.
Why the scale is a blunt instrument
Weight loss on GLP-1 medications is real and substantial. In the STEP 1 trial of semaglutide, participants lost a mean of roughly 15% of body weight over 68 weeks (Wilding et al., NEJM 2021). But total weight is a sum, and a sum hides its parts. When researchers looked inside that weight change using DXA body-composition scans, they found the loss was a mix: total fat mass fell 19.3%, while lean body mass fell 9.7% (STEP 1 body composition analysis, Journal of the Endocrine Society).
That second number is the one the scale will never show you. Across the STEP 1 population, roughly 38–39% of the total weight lost was classified as lean mass on DXA (Barbell Medicine evidence review). Lean mass includes muscle — the tissue that supports strength, metabolic rate, and long-term function. The scale counts a pound of fat and a pound of muscle as the same pound. Your body does not.
The encouraging part of the same data: because fat fell faster than lean mass, the proportion of the body that was lean actually rose by about 3 percentage points, and the lean-to-fat ratio improved from 1.34 toward a higher number, with the biggest improvements in people who lost the most weight (STEP 1 body composition analysis). In other words, body composition can move in a genuinely favorable direction even during rapid weight loss — but you only know that if you measure it.
What's actually worth measuring
Four categories capture what the scale misses. None of these replace your prescribing clinician's guidance; they give you and that clinician better information to work with.
1. Body composition (fat mass vs. lean mass)
This is the headline metric. A DXA scan is the reference-standard tool used in the trials above; bioelectrical impedance (the technology in many smart scales and in-office devices) is less precise but far more accessible and useful for tracking a trend over time when you measure under consistent conditions. What you're watching for is the split: fat mass trending down while lean mass holds relatively steady is the pattern the research associates with higher-quality weight loss (Neeland et al., Diabetes, Obesity and Metabolism 2024).
2. Waist circumference
A cloth tape measure is the cheapest high-value tool you own. An international consensus statement from the IAS and ICCR working group argues that waist circumference should be treated as a routine vital sign, because it "provides both independent and additive information to BMI" and flags cardiometabolic risk that weight alone can miss — identifying higher-risk individuals within every BMI category (Nature Reviews Endocrinology 2020). Waist measurement is a proxy for visceral (abdominal) fat specifically, and it often moves even during a scale plateau. Measure at the same landmark, same time of day, and log it.
3. Metabolic markers
Blood-based biomarkers describe how your metabolism is responding, not just how your body looks. Markers commonly followed alongside weight change include HbA1c (a marker of average blood glucose over roughly three months), fasting insulin (an earlier signal of how hard your metabolism is working to keep glucose in range), and a standard lipid panel. Some people also watch glucose in real time with a continuous glucose monitor. These are ordered and interpreted by your clinician — the value here is establishing a baseline before or early in treatment so that later measurements have something to compare against. A single value is a dot; two values are a line.
4. Strength and physical function
Because lean mass is on the line, a simple record of what your body can do is worth keeping: the weights you use in resistance training, grip strength if you have access to a dynamometer, or even how a flight of stairs feels. Function is the real-world stakes behind the lean-mass number, and it's free to track.
A simple comparison of what to measure
Metric | What it captures | How to measure | Sensible cadence |
|---|---|---|---|
Body composition | Fat mass vs. lean mass split | DXA scan (reference standard) or consistent BIA | Every 8–12 weeks |
Waist circumference | Visceral/abdominal fat trend | Cloth tape at a fixed landmark | Every 2–4 weeks |
Metabolic markers | Glucose and lipid response | Clinician-ordered blood panel | Per clinician's plan |
Strength/function | Muscle quality in daily life | Training log, grip strength | Ongoing |
Body weight | Total mass (context only) | Scale, same conditions | Weekly, as one input |
Weight still belongs on the list — it's just one input among several rather than the verdict.
Why the muscle question keeps coming up
The lean-mass finding is why so much of the current conversation around GLP-1s has moved to protecting muscle. The trial data supports the concern but also points to what's been studied as a mitigating factor: resistance training. In one 2018 meta-analysis of caloric restriction, resistance training was associated with preserving roughly 93% of lean mass compared with diet-only groups, and the research consensus treats the training stimulus itself — with adequate protein intake often cited in the 1.2–1.6 g/kg range — as the primary signal for holding onto muscle during weight loss (Barbell Medicine review; Neeland et al. 2024).
Different medications also show different composition profiles. In SURMOUNT-1, roughly 25% of the weight lost on the highest tirzepatide dose was lean mass, against an average total weight loss near 21% (Barbell Medicine review). These are population averages from clinical trials, not predictions for any one person — which is exactly why individual measurement matters. Whether and how any of this applies to your regimen is a conversation for the clinician managing your care.
Building a baseline you'll actually keep
The best measurement plan is the one you don't abandon by week three. A workable starting point: take a waist measurement and a set of baseline photos this week, ask your clinician which blood markers are already on file so you have a starting line, and schedule a body-composition scan if one is accessible to you. Then pick a cadence — waist every few weeks, composition every couple of months — and write the numbers somewhere you'll see them. Trends beat snapshots. One reading tells you where you are; a series tells you where you're going, and it's the series that keeps you from panicking over a flat week on the scale.
None of this is about chasing a number. It's about making sure the number you're chasing is the right one — fat down, muscle protected, waist shrinking, metabolism responding — instead of the single blunt figure a bathroom scale happens to report.
Sidewalk helps people on GLP-1 and longevity protocols measure what actually matters and see the trends over time, and connects you with cash-pay practitioners who read those numbers with you. If you're ready to track more than your weight, see how Sidewalk works.
